Arbutus Biopharma ($ABUS) Insider Trading & Smart Money Activity

Arbutus Biopharma Corporation · Biotechnology · Latest filing May 12, 2026

Arbutus Biopharma Corporation ($ABUS) has 2 13F position changes on file.

Insider buyers (12 mo): 0
Insider sellers (12 mo): 0
Net insider $ (12 mo): $0
Congress trades (12 mo): 0
13F moves on file: 2
Analyst ratings on file: 0

ABUS insider buying and selling by quarter

Quarter	Congress buys / sales	13F added / cut
Q1 2026	0 / 0	0 / 0
Q2 2026	0 / 0	0 / 2
Q3 2026	0 / 0	0 / 0
Q4 2026	0 / 0	0 / 0

Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.

All ABUS insider, congress, 13F and analyst activity

Date	Source	Who	Action	Shares	Value / amount	ΔOwn	1W	1M	6M	Filing	Story
May 12, 2026	13F	Belvedere Trading	Sold out	-10.72K sh							—
May 12, 2026	13F	Belvedere Trading	Sold out	-10.72K sh							—

1W / 1M / 6M = how ABUS moved from the trade or filing date.

Institutions moving ABUS (13F)

Belvedere Trading2

Frequently asked questions

Which institutions changed their ABUS positions?

Recent 13F filers moving the stock include Belvedere Trading.

Other biotechnology stocks

All stocks Insider cluster buys Top insider purchases Congress 13F institutions

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.

Get trade alerts by text